Clinical trial
Amlodipine in the Prevention and Treatment of Iron Overload in Patients With Thalassemia Major: a Randomized, Controlled Trial
NCT01395199 is registered in ClinicalTrials.gov with University of Campinas, Brazil as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Amlodipine in the Prevention and Treatment of Iron Overload in Patients With Thalassemia Major: a Randomized, Controlled Trial
- Lead sponsor
- University of Campinas, Brazil
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- August 31, 2012
- Completion date
- February 28, 2015
- Enrollment
- 62 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.